2014年

1. Kimura T, Hakuno D, Isoda S, Adachi T: Spontaneous hemostasis of coronary artery aneurysm rupture. Circ J. 2014;78(10):2519-20.
2. Kimura T, Isshiki T, Ogawa H, Yokoi H, Yamaguchi T, Ikeda Y: Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention. J Atheroscler Thromb. 2014 Dec 27.
3. Kimura T, Shiomi H, Kuribayashi S, Isshiki T, Kanazawa S, Ito H, Ikeda S, Forrest B, Zarins CK, Hlatky MA, Norgaard BL: Cost analysis of non-invasive fractional flow reserve derived from coronary computed tomographic angiography in Japan. Cardiovasc Interv Ther. 2015 Jan;30 (1):38-44.
4. Ono K: MicroRNA-133a in the Development of Arteriosclerosis Obliterans. J Atheroscler Thromb. 2015;22(4):342-3.
5. Ashida N, Kishihata M, Tien DN, Kamei K, Kimura T, Yokode M: Aspirin augments the expression of Adenomatous Polyposis Coli protein by suppression of IKKβ. Biochem Biophys Res Commun. 2014 Apr 4;446(2): 460-4.
6. Horie T, Baba O, Kuwabara Y, Yokode M, Kita T, Kimura T, Ono K: MicroRNAs and lipoprotein metabolism. J Atheroscler Thromb. 2014;21 (1):17-22.
7. Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Nakazeki F, Ide Y, Koyama S, Sowa N, Yahagi N, Shimano H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K: MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in vivo. Sci Rep. 2014 Jun 16;4:5312.
8. Imai M, Kimura T, Morimoto T, Saito N, Shiomi H, Kawaguchi R, Kan H, Mukawa H, Fujita H, Ishise T, Hayashi F, Nagao K, Take S, Taniguchi H, Sakamoto H, Yamane T, Shirota K, Tamekiyo H, Okamura T, Kishi K, Miyazaki S, Yamamoto S, Yamaji K, Kawasaki T, Taguchi E, Nakajima H, Kosedo I, Tada T, Kadota K, Mitsudo K: Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy. Cardiovasc Interv Ther. 2014 Jul;29(3):226-36.
9. Tazaki J, Morimoto T, Sakata R, Okabayashi H, Yamazaki F, Nishiwaki N, Mitsudo K, Kimura T: Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection. J Vasc Surg. 2014 Sep;60 (3):604-12.e2.
10. Nishiyama K: Reply to Letter: Possibility of predicting neurological outcome using regional cerebral oxygen saturation (rSO2) after cardiac arrest. Resuscitation. 2014 Sep;85(9):e135.
11. Watanabe S, Horie T, Nagao K, Kuwabara Y, Baba O, Nishi H, Sowa N, Narazaki M, Matsuda T, Takemura G, Wada H, Hasegawa K, Kimura T, Ono K: Cardiac-specific inhibition of kinase activity in calcium/calmodulin- dependent protein kinase kinase-β leads to accelerated left ventricular remodeling and heart failure after transverse aortic constriction in mice. PLoS One. 2014 Sep 25;9(9):e108201.
12. Shiomi H, Kozuma K, Morimoto T, Igarashi K, Kadota K, Tanabe K, Morino Y, Akasaka T, Abe M, Suwa S, Muramatsu T, Kobayashi M, Dai K, Nakao K, Uematsu M, Tarutani Y, Fujii K, Simonton CA, Kimura T: Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: Final 3-year follow-up of the randomized evaluation of sirolimus-eluting versus everolimus-eluting stent trial. Circ Cardiovasc Interv. 2014 Jun;7(3):343-54.
13. Shiomi H, Morimoto T, Makiyama T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Onodera T, Takatsu Y, Mitsudo K, Kita T, Sakata R, Okabayashi H, Hanyu M, Komiya T, Yamazaki F, Nishiwaki N, Kimura T; CREDO-Kyoto Investigators: Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan. Am J Cardiol. 2014 May 15;113(10): 1652-9.
14. Kawaji T, Shiomi H, Morimoto T, Tamura T, Nishikawa R, Yano M, Tazaki J, Imai M, Saito N, Makiyama T, Shizuta S, Ono K, Kimura T: Long-term efficacy and safety outcomes after unrestricted use of drug-eluting stents in patients with acute coronary syndrome: mortality and major bleeding in a single-center registry. Circ J. 2014;78(7):1628-35.
15. Taniguchi T, Shiomi H, Toyota T, Morimoto T, Akao M, Nakatsuma K, Ono K, Makiyama T, Shizuta S, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Horie M, Kimura T: Effect of preinfarction angina pectoris on long-term survival in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Am J Cardiol. 2014 Oct 15;114(8):1179-86.
16. Tien DN, Kishihata M, Yoshikawa A, Hashimoto A, Sabe H, Nishi E, Kamei K, Arai H, Kita T, Kimura T, Yokode M, Ashida N: AMAP1 as a negative-feedback regulator of nuclear factor-κB under inflammatory conditions. Sci Rep. 2014 May 28;4:5094.
17. Abe K, Machida T, Sumitomo N, Yamamoto H, Ohkubo K, Watanabe I, Makiyama T, Fukae S, Kohno M, Harrell DT, Ishikawa T, Tsuji Y, Nogami A, Watabe T, Oginosawa Y, Abe H, Maemura K, Motomura H, Makita N: Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol. 2014 Jun;7(3):511-7.
18. Abe M, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Toma M, Tamura T, Haruna Y, Kita T, Kimura T: Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2014 Aug 1;114(3):362-8.
19. Araki A, Katsuno M, Suzuki K, Banno H, Suga N, Hashizume A, Mano T, Hijikata Y, Nakatsuji H, Watanabe H, Yamamoto M, Makiyama T, Ohno S, Fukuyama M, Morimoto S, Horie M, Sobue G: Brugada syndrome in spinal and bulbar muscular atrophy. Neurology. 2014 May 20;82(20):1813-21.
20. Campos CM, van Klaveren D, Iqbal J, Onuma Y, Zhang YJ, Garcia-Garcia HM, Morel MA, Farooq V, Shiomi H, Furukawa Y, Nakagawa Y, Kadota K, Lemos PA, Kimura T, Steyerberg EW, Serruys PW: Predictive performance of SYNTAX score II in patients with left main and multivessel coronary artery disease - Analysis of CREDO-Kyoto registry. Circ J. 2014;78(8): 1942-9.
21. Fukuyama M, Wang Q, Kato K, Ohno S, Ding WG, Toyoda F, Itoh H, Kimura H, Makiyama T, Ito M, Matsuura H, Horie M: Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes. Europace. 2014 Dec;16(12):1828-37.
22. Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T,Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimra T; CREDO-Kyoto Registry Cohort-2 Investigators: Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Am J Cardiol. 2014 Jul 1;114(1):70-8.
23. Hanazawa K, Kaitani K, Hayama Y, Onishi N, Tamaki Y, Miyake M, Kondo H, Tamura T, Izumi C, Shizuta S, Kimura T, Nakagawa Y: Effect of radiofrequency catheter ablation of persistent atrial fibrillation on the left atrial function: Assessment by 320-row multislice computed tomography. Int J Cardiol. 2015 Jan 20;179:449-54.
24. Hasegawa K, Ohno S, Kimura H, Itoh H, Makiyama T, Yoshida Y, Horie M: Mosaic KCNJ2 Mutation in Andersen-Tawil syndrome: Targeted Deep Sequencing is Useful for the Detection of Mosaicism. Clin Genet. 2015 Mar;87(3):279-83.
25. Hattori N, Nomoto M, Kimura T, Kikuchi S, Enomoto H, Yoshizawa K, Tamaoka A, Hatano T, Murata M, Hasegawa K, Tanaka K, Arahata Y, Kanda F, Kashihara K, Yamamoto M, Nishikawa N, Tsuboi Y, Ohya Y: Sustained efficacy of apomorphine in Japanese patients with advanced Parkinson's disease. Parkinsonism Relat Disord. 2014 Aug;20(8):819-23.
26. Hayashida K, Nishiyama K, Suzuki M, Abe T, Orita T, Ito N, Hori S: Estimated cerebral oxyhemoglobin as a useful indicator of neuroprotection in patients with post-cardiac arrest syndrome: a prospective, multicenter observational study. Crit Care. 2014 Aug 29;18(4):500.
27. Hiraoka Y, Matsuoka T, Ohno M, Nakamura K, Saijo S, Matsumura S, Nishi K, Sakamoto J, Chen P-, Inoue K, Fushiki T, Kita T, Kimura T, Nishi E: Critical roles of nardilysin in the maintenance of body temperature homoeostasis. Nat Commun. 2014;5:3224.
28. Ioroi T, Akao M, Iguchi M, Kato M, Kimura T, Izumi Y, Akaike A, Kume T: Serofendic acid protects against myocardial ischemia-reperfusion injury in rats. J Pharmacol Sci. 2014;126(3):274-80.
29. Ishizu-Higashi S, Seno H, Nishi E, Matsumoto Y, Ikuta K, Tsuda M, Kimura Y, Takada Y, Kimura Y, Nakanishi Y, Kanda K, Komekado H, Chiba T: Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes. PLoS One. 2014 May 21;9(5):e98017.
30. Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Ikeda Y, Nakamura M, Saito S: Prasugrel, a Third-Generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary Intervention: Phase III, randomized, double-blind study. Circ J. 2014;78(12):2926-34.
31. Ito N, Nishiyama K, Callaway CW, Orita T, Hayashida K, Arimoto H, Abe M, Endo T, Murai A, Ishikura K, Yamada N, Mizobuchi M, Anan H, Okuchi K, Yasuda H, Mochizuki T, Tsujimura Y, Nakayama T, Hatanaka T, Nagao K; for the J-POP Registry Investigators: Noninvasive regional cerebral oxygen saturation for neurological prognostication of patients with out-of-hospital cardiac arrest: A prospectivemulticenter observational study. Resuscitation. 2014 Jun;85(6):778-84.
32. Kato M, Kimura T, Kimura T, Hara T: Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression. Neuropsychiatr Dis Treat. 2015 Feb 20;11:435-52.
33. Kawano T, Nishiyama K, Hayashi H: Execution of diagnostic testing has a stronger effect on emergency department crowding than other common factors: a cross-sectional study. PloS one. 2014 Oct 13;9(10):e108447.
34. Kawase Y, Saito N, Watanabe S, Bao B, Yamamoto E, Watanabe H, Higami H, Matsuo H, Ueno K, Kimura T: Utility of a scoring balloon for a severely calcified lesion: bench test and finite element analysis. Cardiovasc Interv Ther. 2014;29:134–9.
35. Ko E, Natsuaki M, Toyofuku M, Morimoto T, Matsumura Y, Oi M, Motohashi Y, Takahashi K, Kawase Y, Tanaka M, Kitada M, Yuzuki Y, Tamura T, Inoue K, Mitsudo K, Kimura T: Sirolimus-eluting stent implantation for ostial right coronary artery lesions: Five-year outcomes from the j-Cypher registry. Cardiovasc Interv Ther. 2014 Jul;29(3):200-8.
36. Kubo T, Akasaka T, Kozuma K, Kimura K, Fusazaki T, Okura H, Shinke T, Ino Y, Hasegawa T, Takashima H, Takamisawa I, Yamaguchi H, Igarashi K, Kadota K, Tanabe K, Nakagawa Y, Muramatsu T, Morino Y, Kimura T: Vascular response to drug-eluting stent with biodegradable vs. durable polymer - Optical coherence tomography substudy of the next. Circ J. 2014;78(10):2408-14.
37. Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R: Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014 Oct 1;114(7):988-96.
38. Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R: Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol. 2014 Aug 15;114(4):555-61.
39. Miyoshi T, Osawa K, Ito H, Kanazawa S, Kimura T, Shiomi H, Kuribayashi S, Jinzaki M, Kawamura A, Bezerra H, Achenbach S, Nørgaard BL: Non-Invasive Computed Fractional Flow Reserve From Computed Tomography (CT) for Diagnosing Coronary Artery Disease – Japanese results from NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). Circ J. 2015;79(2):406-12.
40. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Akasaka T, Tanaka N, Kimura T: Modification of treatment strategy after FFR measurement: CVIT-DEFER registry. Cardiovasc Interv Ther. 2015 Jan;30(1):12-21.
41. Nakamura M, Yamagishi M, Ueno T, Hara K, Ishiwata S, Itoh T, Hamanaka I, Wakatsuki T, Sugano T, Kawai K, Akasaka T, Tanaka N, Kimura T: Prevalence of visual–functional mismatch regarding coronary artery stenosis in the CVIT-DEFER registry. Cardiovasc Interv Ther. 2014 Oct;29(4):300-8.
42. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T: Late adverse events after implantation of sirolimus- eluting stent and bare-metal stent long-term (5-7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2. Circ Cardiovasc Interv. 2014 Apr;7(2):168-79.
43. Natsuaki M, Morimoto T, Furukawa Y, Shiomi H, Ono K, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG Resigsty Cohort-2 investigators: Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥80 years of age: observations from observations from the CREDO-Kyoto Registry Cohort-2. Atherosclerosis 2014 Dec;237(2):821-8.
44. Ohki T, Yokoi H, Kichikawa K, Kimura T, Snyder SA, Ragheb AO, O'Leary EE, Jaff MR, Ansel GM, Dake MD: Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials. J Endovasc Ther. 2014 Oct;21 (5):644-53.
45. Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, Ushinohama H, Makita N, Horie M: Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non- compaction. Europace. 2014 Nov;16(11):1646-54.
46. Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, Takayama M, Kitagawa K, Nishikawa M, Miyazaki S, Nakamura M: Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. Circ J. 2014;78(7):1684-92. Epub 2014 Apr 22.
47. Sasaki N, Kunisawa S, Otsubo T, Ikai H, Fushimi K, Yasumura Y, Kimura T, Imanaka Y: The relationship between the number of cardiologists and clinical practice patterns in acute heart failure: A cross-sectional observational study. BMJ Open. 2014 Dec 30;4(12):e005988.
48. Takabayashi T, Mochizuki T, Otani N, Nishiyama K, Ishimatsu S: Anisakiasis presenting to the ED: clinical Manifestations, time course, hematological test, computed tomographic findings, and treatment. Am J Emerg Med. 2014 Dec;32(12):1485-9.
49. Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Ohishi M, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Imoto Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; on behalf of the CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators: Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv. 2014 Aug;7(4):482-91.
50. Toya T, Hakuno D, Shiraishi Y, Kujiraoka T, Adachi T: Arginase inhibition augments nitric oxide production and facilitates left ventricular systolic function in doxorubicin-induced cardiomyopathy in mice. Physiol Rep. 2014 Sep 28;2(9).
51. Tsutsumi N, Kimura T, Arita K, Ariyoshi M, Ohnishi H, Yamamoto T, Zuo X, Maenaka K, Park EY, Kondo N, Shirakawa M, Tochio H, Kato Z: The structural basis for receptor recognition of human interleukin-18. Nat Commun. 2014 Dec 15;5:5340.
52. Wang Q, Ohno S, Ding WG, Fukuyama M, Miyamoto A, Itoh H, Makiyama T, Wu J, Bai J, Hasegawa K, Shinohara T, Takahashi N, Shimizu A, Matsuura H, Horie M: Gain-of-function KCNH2 mutations in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2014 May;25 (5):522-30.
53. Yamada Y, Kinoshita H, Kuwahara K, Nakagawa Y, Kuwabara Y, Minami T, Yamada C, Shibata J, Nakao K, Cho K, Arai Y, Yasuno S, Nishikimi T, Ueshima K, Kamakura S, Nishida M, Kiyonaka S, Mori Y, Kimura T, Kangawa K, Nakao K: Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure. Cardiovasc Res. 2014 Oct 1;104 (1):183-93.
54. Yamaji K, Kubo S, Inoue K, Kadota K, Kuramitsu S, Shirai S, Ando K, Nobuyoshi M, Mitsudo K, Kimura T: Association of localized hypersensitivity and in-stent neoatherosclerosis with the very late drug-eluting stent thrombosis. PLoS One. 2014 Nov 25;9(11):e113870.
55. Zhou J, Ding WG, Makiyama T, Miyamoto A, Matsumoto Y, Kimura H, Tarutani Y, Zhao J, Wu J, Zang WJ, Matsuura H, Horie M: A novel HCN4 mutation, G1097W, is associated with atrioventricular block. Circ J. 2014;78(4):938-42.

Copyright(C) by Department of the circulatory organs,
Kyoto University Hospital. All Rights Reserved.